Rubius Therapeutics Inc (NASDAQ:RUBY)

18.58
Delayed Data
As of Sep 24
 -0.72 / -3.73%
Today’s Change
4.20
Today|||52-Week Range
38.71
+144.80%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 30.50, with a high estimate of 40.00 and a low estimate of 20.00. The median estimate represents a +64.16% increase from the last price of 18.58.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Rubius Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.55
Sales
$0.00
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.08%
 
 
 
 
 
 
Growthannually -3.29%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.